Tier 2
Ceftriaxone-calcium precipitation
Hemolytic anemia
Kernicterus
Calcium Salts (Intravenous):
May enhance the adverse/toxic effect of CefTRIAXone
Ceftriaxone binds to calcium forming an insoluble precipitate
Management: Use of ceftriaxone is contraindicated in neonates (28 days of age or younger) who require (or are expected to require) treatment with IV calcium-containing solutions
In older patients, flush lines with compatible fluid between administration
Risk D: Consider therapy modification
Rocephin
NOT recommended for S. aureus infections